We use cookies for a better user experience. Read our Privacy Policy

I Agree

Industry Verticals »

All Categories

Insights »

About TMR »

Continuous Glucose Monitoring Market

Download FREE Sample Schedule a Call

Continuous Glucose Monitoring Market

Continuous Glucose Monitoring Market (Device/Brand: Guardian Real Time CGM System, Freestyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, Mini Med Paradigm Revel/Veo Systems, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Continuous Glucose Monitoring Market Outlook 2028

  • The global market was valued at US$ 992.8 Mn in 2020
  • It is estimated to expand at a CAGR of 9.5% from 2021 to 2028
  • The global continuous glucose monitoring devices market is expected to surpass the value of US$ 2 Bn by the end of 2028

Continuous Glucose Monitoring Industry: Overview

  • An increase in the incidence and prevalence rate of diabetes type 1 and type 2 across the globe is anticipated to boost the growth of the global market during the forecast period
  • Continuous glucose monitoring systems are real-time glucose sensing and monitoring devices that measure and display the glucose levels of a patient at regular intervals. The usage of CGM is substantially increasing over traditional glucose monitoring systems, as these systems are user-friendly, provide access to real-time values and trends, and provide enhanced accuracy.
  • Additionally, it has been observed that continuous glucose monitoring significantly helps in diabetes management, especially in type I diabetics, and helps in reducing long-term complications associated with diabetes. A rise in awareness in developed and developing countries, technological advancements, and an increase in the number of diabetic patients are key factors expected to fuel the growth of the global market during the forecast period.

Request a sample to get extensive insights into the Continuous Glucose Monitoring Market

Continuous Glucose Monitoring (CGM) Market: Segmentation

  • The global continuous glucose monitoring market has been segmented based on device/brand and country/sub-region
  • In terms of device/brand, the global continuous glucose monitoring industry has been classified into Guardian Real Time CGM system, Dexcom Seven Plus, Dexcom G4 Platinum, FreeStyle Navigator, MiniMed Paradigm Revel/Veo System, and others
  • The Guardian Real Time CGM System segment accounted for a major market share in 2020, owing to the presence of large companies, such as Medtronic, providing CGM systems in the market for diabetes management. The systems are widely adopted by consumers, as these are considered efficient sensors for usage as fitness trackers for diabetes. The Dexcom G4 Platinum CGM System segment is expected to witness the fastest growth during the forecast period.

To understand how our report can bring a difference to your business strategy, Ask for a brochure

Continuous Glucose Monitoring Market: Country/Sub-region Segmentation

  • In terms of country/sub-region, the global continuous glucose monitoring market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market in 2020, followed by Europe and Asia Pacific. The U.S. accounted for a significant market share in 2020 in the region owing to a large patient pool, increase in the geriatric population, rise in baby boomers, sedentary lifestyles, and undiagnosed diabetic patient population is expected to propel the continuous glucose monitoring devices market in North America. Approvals of innovative CGM systems by the FDA and the rise in innovative companies developing CGM systems are likely to augment the market in the region in the near future.
  • The market in Asia Pacific is likely to grow at a rapid pace from 2021 to 2028. The rapid rise in the diabetic population across the region has increased the demand for effective diabetes management systems. This can be attributed to the surge in the incidence rate of diabetes, an unhealthy lifestyle, technically advanced products, and a rise in the usage of CGM over traditional glucose monitoring systems.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Continuous Glucose Monitoring Market

Continuous Glucose Monitoring Devices Market: Major Players

  • Key players operating in the global continuous glucose monitoring business include
    • Abbott
    • Bayer AG
    • Dexcom, Inc.
    • Glysens Incorporated
    • Insulet Corporation
    • Medtronic
    • Nova Biomedical Corporation
    • Senseonics Incorporated
    • Livongo
    • BeatO
    • Jana Care
    • iXensor
    • DiaMonTech AG
  • These players focus on adopting various strategies to strengthen market presence, expand product offerings, and strengthen geographic presence. Launch of innovative product offerings, mergers & acquisitions, faster approval of CGM devices, and delivering & creating awareness about continuous glucose monitoring systems are projected to boost the growth of the global continuous glucose monitoring market during the forecast period. Entry into the domestic market in developing countries and offering product line at low cost is a key strategy adopted by the major players to expand in emerging markets.

Continuous Glucose Monitoring Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 992.8 Mn

Market Forecast Value in 2028

US$ 2,065.5 Mn

Growth Rate (CAGR)

9.5%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value & ‘000 Units for Volume

Market Analysis

The report includes cross segment analysis at global as well as regional level. Qualitative analysis includes drivers, restraints, opportunities, key trends, etc. The report includes value of various continuous glucose monitoring devices across regional and global level.

Competition Landscape
  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc.

Format

Electronic (PDF) + Excel

Market Segmentation
  • Device/Brand
    • Guardian Real Time CGM System
    • Dexcom Seven Plus
    • Dexcom G4 Platinum
    • FreeStyle Navigator
    • MiniMed Paradigm Revel/Veo System
    • Others

Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled
  • Abbott
  • Bayer AG
  • Dexcom, Inc.
  • Glysens Incorporated
  • Insulet Corporation
  • Medtronic
  • Nova Biomedical Corporation
  • Senseonics Incorporated
  • Livongo
  • BeatO
  • Jana Care
  • iXensor
  • DiaMonTech AG.

Customization Scope

Available upon request

Pricing

Available upon request

Continuous Glucose Monitoring Market – Segmentation

Device/Brand
  • Guardian Real Time CGM System
  • Freestyle Navigator
  • Dexcom Seven Plus CGM System
  • Dexcom G4 Platinum
  • Mini Med Paradigm Revel/Veo Systems
  • Others (iPro 2, Sentrino)
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Continuous Glucose Monitoring Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of continuous glucose monitoring market?

The continuous glucose monitoring (CGM) market is expected to surpass the value of US$ 2 Bn by the end of 2028

What is the anticipated CAGR of the global market for continuous glucose monitoring in the forecast period?

The continuous glucose monitoring market is estimated to expand at a CAGR of 9.5% from 2021 to 2028

What are the key driving factors for the growth of the continuous glucose monitoring devices market?

The continuous glucose monitoring (CGM) market is driven by an increase in the incidence and prevalence rate of diabetes type 1 and type 2 across the globe.

Which region is expected to project the highest market share in the global continuous glucose monitoring business?

North America accounted for a major share of the global CGM market

Who are the key players in the global continuous glucose monitoring industry?

Key players operating in the global continuous glucose monitoring market includes Abbott, Bayer AG, Dexcom, Inc., Glysens Incorporated, Insulet Corporation, Medtronic, Nova Biomedical Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Continuous Glucose Monitoring Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Continuous Glucose Monitoring  Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Prevalence & Incidence rate of Diabetes across globe

    5.3. Pricing Analysis of devices

    5.4. Overview of Point-of-care Testing

    5.5. COVID-19 pandemic impact on Global Continuous Glucose Monitoring Market

6. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Device/Brand

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

        6.3.1. Guardian Real Time CGM System

        6.3.2. FreeStyle Navigator

        6.3.3. Dexcom Seven Plus CGM System

        6.3.4. Dexcom G4 Platinum

        6.3.5. MiniMed Paradigm Revel/Veo Systems

        6.3.6. Others

    6.4. Global  Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand,2021–2028

7. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Country/Sub-region

    7.1. Key Findings

    7.2. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Region

        7.2.1. North America

        7.2.2. Europe

        7.2.3. Asia Pacific

        7.2.4. Latin America

        7.2.5. Middle East & Africa

    7.3. Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Region,2017–2028

8. North America Continuous Glucose Monitoring Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

    8.2. North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

        8.2.1. Guardian Real Time CGM System

        8.2.2. FreeStyle Navigator

        8.2.3. Dexcom Seven Plus CGM System

        8.2.4. Dexcom G4 Platinum

        8.2.5. MiniMed Paradigm Revel/Veo Systems

        8.2.6. Others

    8.3. North America Continuous Glucose Monitoring Market Analysis, by Country, 2017–2028

        8.3.1. U.S.

        8.3.2. Canada

    8.4. North America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

        8.4.1. By Device/Brand

        8.4.2. By Country/Sub-region

9. Europe Continuous Glucose Monitoring  Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

        9.2.1. Guardian Real Time CGM System

        9.2.2. FreeStyle Navigator

        9.2.3. Dexcom Seven Plus CGM System

        9.2.4. Dexcom G4 Platinum

        9.2.5. MiniMed Paradigm Revel/Veo Systems

        9.2.6. Others

    9.3. Europe Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028

        9.3.1. Germany

        9.3.2. U.K.

        9.3.3. France

        9.3.4. Italy

        9.3.5. Spain

        9.3.6. Rest of Europe

    9.4. Europe Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

        9.4.1. By Device/Brand

        9.4.2. By Country/Sub-region

10. Asia Pacific Continuous Glucose Monitoring Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

        10.2.1. Guardian Real Time CGM System

        10.2.2. FreeStyle Navigator

        10.2.3. Dexcom Seven Plus CGM System

        10.2.4. Dexcom G4 Platinum

        10.2.5. MiniMed Paradigm Revel/Veo Systems

    10.3. Asia Pacific Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028

        10.3.1. China

        10.3.2. Japan

        10.3.3. India

        10.3.4. Australia & New Zealand

        10.3.5. Rest of Asia Pacific

    10.4. Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

        10.4.1. By Device/Brand

        10.4.2. By Country/Sub-region

11. Latin America Continuous Glucose Monitoring Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

        11.2.1. Guardian Real Time CGM System

        11.2.2. FreeStyle Navigator

        11.2.3. Dexcom Seven Plus CGM System

        11.2.4. Dexcom G4 Platinum

        11.2.5. MiniMed Paradigm Revel/Veo Systems

    11.3. Latin America Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028

        11.3.1. Brazil

        11.3.2. Mexico

        11.3.3. Rest of Latin America

    11.4. Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

        11.4.1. By Device/Brand

        11.4.2. By Country/Sub-region

12. Middle East & Africa Continuous Glucose Monitoring Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

        12.2.1. Guardian Real Time CGM System

        12.2.2. FreeStyle Navigator

        12.2.3. Dexcom Seven Plus CGM System

        12.2.4. Dexcom G4 Platinum

        12.2.5. MiniMed Paradigm Revel/Veo Systems

    12.3. Middle East & Africa Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028

        12.3.1. GCC Countries

        12.3.2. South Africa

        12.3.3. Rest of Middle East & Africa

    12.4. Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

        12.4.1. By Device/Brand

        12.4.2. By Country/Sub-region

13. Competitive Landscape

    13.1. Company Profiles (2020)

        13.1.1. Abbott

            13.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.1.2. Product Portfolio

            13.1.1.3. Financial Overview

            13.1.1.4. Strategic Overview

            13.1.1.5. SWOT Analysis

        13.1.2. Bayer AG

            13.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.2.2. Product Portfolio

            13.1.2.3. Financial Overview

            13.1.2.4. Strategic Overview

            13.1.2.5. SWOT Analysis

        13.1.3. Dexcom, Inc.

            13.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.3.2. Product Portfolio

            13.1.3.3. Financial Overview

            13.1.3.4. Strategic Overview

            13.1.3.5. SWOT Analysis

        13.1.4. Glysens Incorporated

            13.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.4.2. Product Portfolio

            13.1.4.3. Strategic Overview

            13.1.4.4. SWOT Analysis

        13.1.5. Insulet Corporation

            13.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.5.2. Product Portfolio

            13.1.5.3. Financial Overview

            13.1.5.4. Strategic Overview

            13.1.5.5. SWOT Analysis

        13.1.6. Medtronic

            13.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.6.2. Product Portfolio

            13.1.6.3. Financial Overview

            13.1.6.4. Strategic Overview

            13.1.6.5. SWOT Analysis

        13.1.7. Nova Biomedical Corporation

            13.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.7.2. Product Portfolio

            13.1.7.3. Financial Overview

            13.1.7.4. Strategic Overview

            13.1.7.5. SWOT Analysis

        13.1.8. Senseonics Incorporated

            13.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.8.2. Product Portfolio

            13.1.8.3. Strategic Overview

            13.1.8.4. SWOT Analysis

        13.1.9. Livongo

            13.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.9.2. Product Portfolio

            13.1.9.3. Strategic Overview

            13.1.9.4. SWOT Analysis

        13.1.10. BeatO

            13.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.10.2. Product Portfolio

            13.1.10.3. Strategic Overview

            13.1.10.4. SWOT Analysis

        13.1.11. Jana Care

            13.1.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.11.2. Product Portfolio

            13.1.11.3. Strategic Overview

            13.1.11.4. SWOT Analysis

        13.1.12. iXensor

            13.1.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.12.2. Product Portfolio

            13.1.12.3. Strategic Overview

            13.1.12.4. SWOT Analysis

        13.1.13. DiaMonTech AG

            13.1.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.1.13.2. Product Portfolio

            13.1.13.3. Financial Overview

            13.1.13.4. Strategic Overview

            13.1.13.5. SWOT Analysis

List of Tables

Table 01: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

Table 02: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

Table 03: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

Table 04: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

Table 05: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017‒2028

Table 06: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017‒2028

Table 07: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

Table 08: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by End-user, 2017–2028

Table 09: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Region, 2017–2028

Table 10: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028

Table 11: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

Table 12: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

Table 13: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

Table 14: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

Table 15: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028

Table 16: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028

Table 17: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

Table 18: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 19: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

Table 20: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

Table 21: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

Table 22: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

Table 23: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028

Table 24: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028

Table 25: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

Table 26: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028

Table 27: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

Table 28: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

Table 29: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

Table 30: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

Table 31: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028

Table 32: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028

Table 33: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

Table 34: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028

Table 35: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

Table 36: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

Table 37: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

Table 38: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

Table 39: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028

Table 40: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028

Table 41: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

Table 42: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028

Table 43: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

Table 44: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

Table 45: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

List of Figures

Figure 01: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028

Figure 02: Global Continuous Glucose Monitoring Market Value Share, by Device/Brand, 2020

Figure 03: Global Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

Figure 04: Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

Figure 05: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Guardian Real Time CGM System, 2017‒2028

Figure 06: Global Continuous Glucose Monitoring Market Value (US$ Mn), by FreeStyle Navigator, 2017‒2028

Figure 07: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Dexcom Seven Plus CGM System, 2017‒2028

Figure 08: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Dexcom G4 Platinum, 2017‒2028

Figure 09: Global Continuous Glucose Monitoring Market Value (US$ Mn), by MiniMed Paradigm Revel/Veo Systems, 2017‒2028

Figure 10: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Others, 2017‒2028

Figure 11: Global Continuous Glucose Monitoring Market Value Share Analysis, by Region, 2020 and 2028

Figure 12: Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Region, 2021–2028

Figure 13: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028

Figure 14: North America Continuous Glucose Monitoring Market Value Share Analysis, by Country, 2020 and 2028

Figure 15: North America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country, 2021–2028

Figure 16: North America Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

Figure 17: North America Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

Figure 18: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028

Figure 19: Europe Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub–region, 2020 and 2028

Figure 20: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Sub–region, 2021–2028

Figure 21: Europe Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

Figure 22: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

Figure 23: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028

Figure 24: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 25: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028

Figure 26: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

Figure 27: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

Figure 28: Latin America Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 29: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028

Figure 30: Latin America Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

Figure 31: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

Figure 32: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 33: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028

Figure 34: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

Figure 35: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

Figure 36: North America - Company Share Analysis, 2020

Figure 37: Europe - Company Share Analysis, 2020

Figure 38: Asia Pacific - Company Share Analysis, 2020

Figure 39: Latin America - Company Share Analysis, 2020

Figure 40: Middle East & Africa - Company Share Analysis, 2020

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

675

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved